Answers are grounded in this paper and cite their sources.
Various screening techniques have been developed for preimplantation genetic testing for aneuploidy (PGT-A) to reduce implantation failure and miscarriages in women undergoing in vitro fertilisation (IVF) treatment. Among these methods, the Oxford nanopore technology (ONT) has already been tested in several tissues. However, no studies have applied ONT to polar bodies, a cellular material that is less restrictively regulated for PGT-A in some countries.
No takes yet. Share an insight, caveat, or question.
Madritsch et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: